• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

MRC PhD studentship: Novel pro-longevity compounds for the treatment of neurodegenerative diseases

studentship jobs

  • Please log in to reply
No replies to this topic
⌛⇒ MITOMOUSE has been fully funded!

#1 jpnitya

  • Guest
  • 17 posts
  • 14
  • Location:Liverpool, UK

Posted 05 January 2016 - 09:01 PM


We are accepting applications for an MRC-funded PhD studentship available for start in the autumn of 2016. We are looking for an enthusiastic and ambitious student to study and characterize new compounds with life-extending, health-preserving and neuroprotective effects that may be suitable for the treatment of neurodegenerative diseases. Our lab has recently identified several novel life-extending drugs. In this project, we aim to further study these compounds for lifespan and healthspan effects in worm models of neurodegenerative diseases. Furthermore, this is a collaborative project with researchers in Newcastle and Sheffield, and studies in mammalian cells will be performed to assay for potential effects relevant to humans. The exact direction of this project and methods to be used, however, will be adapted to fit the research interests and background of the student.

More information about the project and the MRC Doctoral Training Partnership is available online:
http://science-marke...e-diseases_i542
To submit an application:
http://www.dimen.org...cation-overview

The deadline for applications will be 22nd January, 2016.  Due to UK government restrictions, this studentship is only available to UK citizens and residents. Self-funded students are also invited to apply for this project, however.

Potentially interested students are welcome to contact us (aging@liv.ac.uk or 0151 7954517) for an informal discussion.

Thank you very much,
Joao Pedro







Also tagged with one or more of these keywords: studentship, jobs

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users